The purpose of this study is to explore the value of new MR technology in assessing the systemic metabolism, disease status, and prognostic risk of metabolism-related fatty liver disease. By obtaining clinical, imaging, laboratory examination and pathological data of metabolism-related fatty liver disease, image processing software is used to analyze the images, explore the relationship between imaging parameters, body composition and metabolic diseases and metabolism-related fatty liver disease, and achieve non-invasive diagnosis, efficacy evaluation, and prognosis prediction of metabolism-related fatty liver disease. Thereby guiding clinical treatment and improving the prognosis and quality of life of patients with metabolism-related fatty liver disease
Patients with MR examination are clinically suspected or diagnosed with metabolism-related fatty liver disease;
Age/gender: unlimited;
Patients who voluntarily participate in clinical trials and sign written subject informed consent
Clinical suspicion or diagnosis of metabolism-related fatty liver disease and having been prescribed an MR examination;
Voluntarily participation in the study and provision of written informed consent.